| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |